Subtopic Deep Dive

Fraser Syndrome Ocular Manifestations
Research Guide

What is Fraser Syndrome Ocular Manifestations?

Fraser Syndrome Ocular Manifestations refer to eye defects including cryptophthalmos, lacrimal duct anomalies, and corneal opacities caused by mutations in FRAS1 and FREM2 genes in this autosomal recessive multisystem disorder.

Fraser syndrome features cryptophthalmos where skin covers the eye without lid separation, alongside syndactyly and urogenital malformations. Clinical studies correlate FRAS1/Fras1 mutations with blebbed mouse phenotypes (McGregor et al., 2003, 257 citations). FREM2 mutations link to myelencephalic blebs in mouse models (Jadeja et al., 2005, 164 citations). Over 20 papers detail genotype-phenotype associations.

Curated Papers

Key Challenges

Why It Matters

Fraser syndrome ocular manifestations guide genetic counseling and surgical planning for cryptophthalmos reconstruction. McGregor et al. (2003) identified FRAS1 mutations enabling prenatal diagnosis via mutation screening. Slavotinek and Tifft (2002) defined diagnostic criteria including cryptophthalmos frequency in 69% of cases, improving multisystem management. Thomas et al. (1986) distinguished isolated from syndromic cryptophthalmos, aiding differential diagnosis in 200+ cited cases.

Key Research Challenges

Genotype-Phenotype Correlation

Variable expressivity links FRAS1/FREM2 mutations to cryptophthalmos severity inconsistently. McGregor et al. (2003) showed mouse Fras1 mutants with partial eyelid fusion. Jadeja et al. (2005) reported FREM2 defects causing similar blebs, complicating predictions.

Cryptophthalmos Classification

Distinguishing complete, incomplete, and abortive cryptophthalmos types hinders diagnosis. Thomas et al. (1986) reviewed 100 cases separating isolated from syndromic forms. Slavotinek and Tifft (2002) proposed phenotypic modules for Fraser syndrome criteria.

Extracellular Matrix Defects

FRAS1 protein disruptions in basement membranes cause eyelid fusion. Takamiya et al. (2004) linked GRIP1 to Fras1 function in matrix stability. Mouse models reveal embryonic lethality challenges (McGregor et al., 2003).

Essential Papers

Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein

Lesley McGregor, Ville Makela, S. M. Darling et al. · 2003 · Nature Genetics · 257 citations

Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes

Anne Slavotinek, C J Tifft · 2002 · Journal of Medical Genetics · 234 citations

Fraser syndrome is characterised by cryptophthalmos, cutaneous syndactyly, malformations of the larynx and genitourinary tract, craniofacial dysmorphism, orofacial clefting, mental retardation, and...

<i>Chx10</i>repression of<i>Mitf</i>is required for the maintenance of mammalian neuroretinal identity

D. Jonathan Horsford, Minh‐Thanh Nguyen, Grant C. Sellar et al. · 2004 · Development · 209 citations

During vertebrate eye development, the cells of the optic vesicle (OV)become either neuroretinal progenitors expressing the transcription factor Chx10, or retinal pigment epithelium (RPE) progenito...

Isolated and syndromic cryptophthalmos

I. T. Thomas, Jaime L. Frías, V. Félix et al. · 1986 · American Journal of Medical Genetics · 200 citations

Abstract The association between cryptophthalmos and multiple congenital malformations has been well documented over the last century. Numerous authors have described case as the cryptophthalmos sy...

Temporal perturbations in sonic hedgehog signaling elicit the spectrum of holoprosencephaly phenotypes

Dwight R. Cordero, Ralph Marcucio, Diane Hu et al. · 2004 · Journal of Clinical Investigation · 181 citations

One of the most perplexing questions in clinical genetics is why patients with identical gene mutations oftentimes exhibit radically different clinical features. This inconsistency between genotype...

Six3 activation of Pax6 expression is essential for mammalian lens induction and specification

Wei Liu, Oleg V. Lagutin, Michael Mende et al. · 2006 · The EMBO Journal · 165 citations

Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs

Shalini Jadeja, Ian Smyth, Jolanta E. Pitera et al. · 2005 · Nature Genetics · 164 citations

Reading Guide

Foundational Papers

Start with McGregor et al. (2003) for FRAS1 discovery and mouse models, then Slavotinek and Tifft (2002) for cryptophthalmos criteria, and Thomas et al. (1986) for syndromic classification.

Recent Advances

Jadeja et al. (2005) on FREM2 mutations; Takamiya et al. (2004) on Fras1-GRIP1 links; Ragge et al. (2007) on anophthalmia management applicable to cryptophthalmos.

Core Methods

Gene sequencing for FRAS1/FREM2, mouse bleb phenotyping, phenotypic module analysis, and diagnostic criteria scoring (Slavotinek and Tifft, 2002).

How PapersFlow Helps You Research Fraser Syndrome Ocular Manifestations

Discover & Search

Research Agent uses searchPapers for 'Fraser syndrome cryptophthalmos FRAS1 mutations' retrieving McGregor et al. (2003), then citationGraph maps 257 citing papers on FREM2 correlations, and findSimilarPapers expands to Jadeja et al. (2005). exaSearch queries 'cryptophthalmos diagnostic criteria' surfacing Slavotinek and Tifft (2002).

Analyze & Verify

Analysis Agent applies readPaperContent to extract mutation data from McGregor et al. (2003), verifyResponse with CoVe checks genotype-phenotype claims against Thomas et al. (1986), and runPythonAnalysis parses citation networks for co-occurrence of FRAS1/FREM2 in 50+ papers. GRADE grading scores evidence strength for cryptophthalmos prevalence at high confidence.

Synthesize & Write

Synthesis Agent detects gaps in FRAS1 surgical outcome studies via contradiction flagging across McGregor et al. (2003) and Slavotinek reviews. Writing Agent uses latexEditText for case report drafting, latexSyncCitations integrates 10 Fraser papers, latexCompile generates PDF, and exportMermaid visualizes mutation-phenotype flowcharts.

Use Cases

"Statistical correlation of FRAS1 mutations with cryptophthalmos severity in Fraser syndrome cases"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas correlation on mutation frequencies from McGregor et al. 2003 and Jadeja et al. 2005 abstracts) → CSV table of p-values and odds ratios.

"Draft LaTeX review on Fraser syndrome ocular phenotypes with citations"

Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections on cryptophthalmos) → latexSyncCitations (add McGregor 2003, Slavotinek 2002) → latexCompile → peer-ready PDF.

"Find code analyzing Fraser mouse model phenotypes"

Research Agent → paperExtractUrls (from McGregor 2003 supplements) → paperFindGithubRepo → githubRepoInspect → Python scripts for bleb phenotype quantification.

Automated Workflows

Deep Research workflow scans 50+ Fraser papers via searchPapers → citationGraph → structured report on FRAS1/FREM2 ocular mutations. DeepScan applies 7-step CoVe verification to Slavotinek (2002) criteria against Thomas (1986) cases. Theorizer generates hypotheses linking Chx10/Mitf pathways (Horsford et al., 2004) to cryptophthalmos from FRAS1 defects.

Try Doxa for Fraser Syndrome Ocular Manifestations Research

Frequently Asked Questions

What defines Fraser syndrome ocular manifestations?

Cryptophthalmos (complete/incomplete), lacrimal duct aplasia, and corneal anomalies from FRAS1/FREM2 mutations (Slavotinek and Tifft, 2002).

What methods screen for Fraser syndrome genes?

Mutation screening of FRAS1/Fras1 via sequencing, validated in mouse bleb models (McGregor et al., 2003; Jadeja et al., 2005).

What are key papers on cryptophthalmos in Fraser syndrome?

McGregor et al. (2003, 257 citations) on FRAS1; Slavotinek and Tifft (2002, 234 citations) on diagnostic criteria; Thomas et al. (1986, 200 citations) on syndromic forms.

What open problems exist in Fraser ocular research?

Incomplete genotype-phenotype maps for variable cryptophthalmos expressivity and limited surgical outcome data post-FRAS1 diagnosis (Takamiya et al., 2004).